Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q2 FY23 results · Jul–Sep 2022
Camlin Fine Sciences reported revenue from operations of ₹483.25 crore (up 55.3% from Q2 FY22) and net profit of ₹9.87 crore for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 483.25 | 311.22 | +55.3% | 383.77 | +25.9% |
| Other income | 2.88 | 0.62 | +364.0% | 1.03 | +180.4% |
| Total income | 486.12 | 311.84 | +55.9% | 384.80 | +26.3% |
| Profit before tax | 25.61 | 0.91 | 28x | 14.55 | +76.1% |
| Net profit for the period | 9.87 | (3.88) | Turned profit | 3.60 | +174.3% |
| Attributable to shareholders of the company | 13.02 | (5.53) | Turned profit | 5.89 | +121.1% |
| EPS, basic (₹) | 0.83 | (0.43) | not comparable | 0.37 | +124.3% |
| Net margin (%) | 2.0 | -1.2 | 0.9 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 243.15 | 138.17 | +76.0% | 155.44 | +56.4% |
| Other income | 12.10 | 1.01 | 12x | 12.74 | −5.0% |
| Total income | 255.25 | 139.17 | +83.4% | 168.17 | +51.8% |
| Profit before tax | 30.69 | (10.15) | Turned profit | 5.16 | +495.0% |
| Net profit for the period | 18.68 | (6.99) | Turned profit | 5.27 | +254.2% |
| EPS, basic (₹) | 1.19 | (0.55) | not comparable | 0.34 | +250.0% |
| Net margin (%) | 7.7 | -5.1 | 3.4 |
Consolidated
- Filed with BSE
- 13 Nov 2022, 13:09 IST
- Board meeting
- 31 Mar 2023
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Nov 2022, 13:09 IST
- Board meeting
- 12 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE